How Moonshot Medical Sources BPC-157 Moonshot Medical works with a licensed 503A compounding pharmacy that provides pharmaceutical-grade BPC-157
Seek urgent or emergency medical care for difficulty breathing, swelling of the face or throat, fainting, a severe allergic reaction or another potentially life-threatening symptom
Wound healing acceleration: Multiple studies confirm GHK-Cu shortens healing time for skin injuries, surgical wounds, and chronic ulcers by promoting angiogenesis and keratinocyte migration
Frequency: Administer one subcutaneous injection daily for length of cycle
What exists is: In-vitro CYP3A4 inhibition data for rhodiola constituents 4 5 Clinical BP-lowering data for rhodiola from small trials 6 Well-established CYP3A4 dependence for amlodipine clearance 1 2 Extrapolated risk based on analogous CYP3A4-substrate interactions with other weak inhibitors 22 What does not yet exist is a randomized crossover pharmacokinetic study measuring amlodipine AUC and Cmax with and without rhodiola co-administration
Citation: Pickart L, Vasquez-Soltero JM, Margolina A